IGFBP2 was shown to stimulate ovarian cancer cell invasion [77], and Baron-Hay et al. [78] have revealed the clinical relevance of IGFBP2 as a prognostic marker against ovarian cancer. This evidence concerns the gene IGFBP2 and ovarian carcinoma.